Validity of messenger RNA expression analyses of human saliva

被引:35
作者
Kumar, Shalini V.
Hurteau, Gregory J.
Spivack, Simon D.
机构
[1] New York State Dept Hlth, Wadsworth Ctr Labs & Res, Lab Human Toxicol & Mol Epidemiol, Albany, NY 12201 USA
[2] Ordway Res Inst, Albany, NY USA
[3] Albany Med Coll, Albany, NY 12208 USA
[4] SUNY, Sch Publ Hlth, Rensselaer, NY USA
关键词
D O I
10.1158/1078-0432.CCR-06-0501
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The origins of expression microarray and reverse transcription-PCR (RT-PCR) signals in human saliva were evaluated. Experimental Design: The "RNA" extracts from human saliva samples were treated with vehicle, DNase, or RNase. Two-step amplification and hybridization to Affymetrix 133A cDNA microarrays were then done. Confirmatory RT-PCR experiments used conventionally designed PCR primer pairs for the reference housekeeper transcripts encoding 36134, beta-actin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA sequences, which are known to be homologous to genomic DNA pseudogene sequences. Negative controls included the omission of reverse transcriptase ("no-RT") to detect any DNA-derived signal. Finally, an RNA-specific RT-PCR strategy eliminated confounding signals from contaminating genomic DNA. Results: Microarray experiments revealed that untreated, DNase-treated, and RNase-treated "RNA" extracts from saliva all yielded negligible overall signals. Specific microarray signals for 36B4, beta-actin, and GAPDH were low, and were unaffected by RNase. Real-time quantitative RT-PCR reactions using conventional, non - RNA-specific primers on saliva samples yielded PCR products for 36B4, beta-actin, and GAPDH; DNase-treated saliva samples did not yield a PCR product, and the "no-RT" and "+RT" conditions yielded similar amounts of PCR product. The RNA-specific RT-PCR strategy, across all conditions, yielded no PCR product from saliva. Conclusions: The combination of (a) a minimal microarray signal, which was unaffected by RNase treatment, (b) the presence of a conventional RT-PCR housekeeper product in both RNase-treated and no-RT saliva samples, (c) the absence of a conventional RT-PCR housekeeper product in DNase-treated conditions, and (d) the absence of a RNA-specific RT-PCR product shows that any microarray or RT-PCR signal in the saliva must arise from genomic DNA, not RNA. Thus, saliva extracts do not support mRNA expression studies.
引用
收藏
页码:5033 / 5039
页数:7
相关论文
共 16 条
[1]  
Bustin Stephen A, 2004, J Biomol Tech, V15, P155
[2]   Estrogen receptor α increases basad and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells [J].
Han, W ;
Pentecost, BT ;
Pietropaolo, RL ;
Fasco, MJ ;
Spivack, SD .
MOLECULAR CARCINOGENESIS, 2005, 44 (03) :202-211
[3]   mRNA-specific reverse transcription-polymerase chain reaction from human tissue extracts [J].
Hurteau, GJ ;
Spivack, SD .
ANALYTICAL BIOCHEMISTRY, 2002, 307 (02) :304-315
[4]   Quantification using real-time PCR technology: applications and limitations [J].
Klein, D .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (06) :257-260
[5]  
Lacroix J, 2001, INT J CANCER, V92, P1
[6]   Salivary transcriptome diagnostics for oral cancer detection [J].
Li, Y ;
St John, MAR ;
Zhou, XF ;
Kim, Y ;
Sinha, U ;
Jordan, RCK ;
Eisele, D ;
Abemayor, E ;
Elashoff, D ;
Park, NH ;
Wong, DT .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8442-8450
[7]   RNA profiling of cell-free saliva using microarray technology [J].
Li, Y ;
Zhou, X ;
John, MARS ;
Wong, DTW .
JOURNAL OF DENTAL RESEARCH, 2004, 83 (03) :199-203
[8]  
Lion T, 2001, LEUKEMIA, V15, P1033, DOI 10.1038/sj.leu.2402133
[9]   Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR [J].
Lupberger, J ;
Kreuzer, KA ;
Baskaynak, G ;
Peters, UR ;
le Coutre, P ;
Schmidt, CA .
MOLECULAR AND CELLULAR PROBES, 2002, 16 (01) :25-30
[10]   Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment [J].
Miller, CS ;
Avdiushko, SA ;
Kryscio, RJ ;
Danaher, RJ ;
Jacob, RJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (05) :2173-2180